Adempas Tablets and Linagliptin and Metformin Extended-Release Tablets
Determining the interaction of Adempas Tablets and Linagliptin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-Linagliptin and Metformin Tablets
- Adempas Tablets-Lincocin
- Adempas Tablets-Lincomycin
- Adempas Tablets-Lincomycin Hydrochloride
- Adempas Tablets-Lincomycin Injection
- Adempas Tablets-Lincomycin Oral, Injection
- Linagliptin and Metformin Extended-Release Tablets-Adenocard
- Linagliptin and Metformin Extended-Release Tablets-Adenoscan
- Linagliptin and Metformin Extended-Release Tablets-Adenosine
- Linagliptin and Metformin Extended-Release Tablets-Adenosine Intravenous
- Linagliptin and Metformin Extended-Release Tablets-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Linagliptin and Metformin Extended-Release Tablets-Adenovirus Vaccine